Cargando…

High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation

BACKGROUND: High-flow nasal cannula (HFNC) is increasingly used in critically ill cancer patients with acute respiratory failure (ARF) to avoid mechanical ventilation (MV). The objective was to assess prognostic factors associated with mortality in ICU cancer patients requiring MV after HFNC failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Saillard, Colombe, Lambert, Jérôme, Tramier, Morgane, Chow-Chine, Laurent, Bisbal, Magali, Servan, Luca, Gonzalez, Frederic, de Guibert, Jean-Manuel, Faucher, Marion, Sannini, Antoine, Mokart, Djamel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242496/
https://www.ncbi.nlm.nih.gov/pubmed/35767521
http://dx.doi.org/10.1371/journal.pone.0270138
_version_ 1784738072291704832
author Saillard, Colombe
Lambert, Jérôme
Tramier, Morgane
Chow-Chine, Laurent
Bisbal, Magali
Servan, Luca
Gonzalez, Frederic
de Guibert, Jean-Manuel
Faucher, Marion
Sannini, Antoine
Mokart, Djamel
author_facet Saillard, Colombe
Lambert, Jérôme
Tramier, Morgane
Chow-Chine, Laurent
Bisbal, Magali
Servan, Luca
Gonzalez, Frederic
de Guibert, Jean-Manuel
Faucher, Marion
Sannini, Antoine
Mokart, Djamel
author_sort Saillard, Colombe
collection PubMed
description BACKGROUND: High-flow nasal cannula (HFNC) is increasingly used in critically ill cancer patients with acute respiratory failure (ARF) to avoid mechanical ventilation (MV). The objective was to assess prognostic factors associated with mortality in ICU cancer patients requiring MV after HFNC failure, and to identify predictive factors of intubation. METHODS: We conducted a retrospective study from 2012–2016 in a cancer referral center. All consecutive onco-hematology adult patients admitted to the ICU treated with HFNC were included. HFNC failure was defined by intubation requirement. RESULTS: 202 patients were included, 104 successfully treated with HFNC and 98 requiring intubation. ICU and hospital mortality rates were 26.2% (n = 53) and 42.1% (n = 85) respectively, and 53.1% (n = 52) and 68.4% (n = 67) in patients requiring MV. Multivariate analysis identified 4 prognostic factors of hospital mortality after HFNC failure: complete/partial remission (OR = 0.2, 95%CI = 0.04–0.98, p<0.001) compared to patients with refractory/relapse disease (OR = 3.73, 95%CI = 1.08–12.86), intubation after day 3 (OR = 7.78, 95%CI = 1.44–41.96), number of pulmonary quadrants involved on chest X-ray (OR = 1.93, 95%CI = 1.14–3.26, p = 0.01) and SAPSII at ICU admission (OR = 1.06, 95%CI = 1–1.12, p = 0.019). Predictive factors of intubation were the absence of sepsis (sHR = 0.32, 95%CI = 0.12–0.74, p = 0.0087), Sp02<95% 15 minutes after HFNC initiation (sHR = 2.05, 95%CI = 1.32–3.18, p = 0.0014), number of quadrants on X-ray (sHR = 1.73, 95%CI = 1.46–2.06, p<0.001), Fi02>60% at HFNC initiation (sHR = 3.12, 95%CI = 2.06–4.74, p<0.001) and SAPSII at ICU admission (sHR = 1.03, 95%CI = 1.02–1.05, p<0.01). CONCLUSION: Duration of HFNC may be predictive of an excess mortality in ARF cancer patients. Early warning scores to predict HFNC failure are needed to identify patients who would benefit from early intubation.
format Online
Article
Text
id pubmed-9242496
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-92424962022-06-30 High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation Saillard, Colombe Lambert, Jérôme Tramier, Morgane Chow-Chine, Laurent Bisbal, Magali Servan, Luca Gonzalez, Frederic de Guibert, Jean-Manuel Faucher, Marion Sannini, Antoine Mokart, Djamel PLoS One Research Article BACKGROUND: High-flow nasal cannula (HFNC) is increasingly used in critically ill cancer patients with acute respiratory failure (ARF) to avoid mechanical ventilation (MV). The objective was to assess prognostic factors associated with mortality in ICU cancer patients requiring MV after HFNC failure, and to identify predictive factors of intubation. METHODS: We conducted a retrospective study from 2012–2016 in a cancer referral center. All consecutive onco-hematology adult patients admitted to the ICU treated with HFNC were included. HFNC failure was defined by intubation requirement. RESULTS: 202 patients were included, 104 successfully treated with HFNC and 98 requiring intubation. ICU and hospital mortality rates were 26.2% (n = 53) and 42.1% (n = 85) respectively, and 53.1% (n = 52) and 68.4% (n = 67) in patients requiring MV. Multivariate analysis identified 4 prognostic factors of hospital mortality after HFNC failure: complete/partial remission (OR = 0.2, 95%CI = 0.04–0.98, p<0.001) compared to patients with refractory/relapse disease (OR = 3.73, 95%CI = 1.08–12.86), intubation after day 3 (OR = 7.78, 95%CI = 1.44–41.96), number of pulmonary quadrants involved on chest X-ray (OR = 1.93, 95%CI = 1.14–3.26, p = 0.01) and SAPSII at ICU admission (OR = 1.06, 95%CI = 1–1.12, p = 0.019). Predictive factors of intubation were the absence of sepsis (sHR = 0.32, 95%CI = 0.12–0.74, p = 0.0087), Sp02<95% 15 minutes after HFNC initiation (sHR = 2.05, 95%CI = 1.32–3.18, p = 0.0014), number of quadrants on X-ray (sHR = 1.73, 95%CI = 1.46–2.06, p<0.001), Fi02>60% at HFNC initiation (sHR = 3.12, 95%CI = 2.06–4.74, p<0.001) and SAPSII at ICU admission (sHR = 1.03, 95%CI = 1.02–1.05, p<0.01). CONCLUSION: Duration of HFNC may be predictive of an excess mortality in ARF cancer patients. Early warning scores to predict HFNC failure are needed to identify patients who would benefit from early intubation. Public Library of Science 2022-06-29 /pmc/articles/PMC9242496/ /pubmed/35767521 http://dx.doi.org/10.1371/journal.pone.0270138 Text en © 2022 Saillard et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Saillard, Colombe
Lambert, Jérôme
Tramier, Morgane
Chow-Chine, Laurent
Bisbal, Magali
Servan, Luca
Gonzalez, Frederic
de Guibert, Jean-Manuel
Faucher, Marion
Sannini, Antoine
Mokart, Djamel
High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation
title High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation
title_full High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation
title_fullStr High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation
title_full_unstemmed High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation
title_short High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation
title_sort high-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: moving from avoiding intubation to avoiding delayed intubation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242496/
https://www.ncbi.nlm.nih.gov/pubmed/35767521
http://dx.doi.org/10.1371/journal.pone.0270138
work_keys_str_mv AT saillardcolombe highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT lambertjerome highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT tramiermorgane highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT chowchinelaurent highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT bisbalmagali highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT servanluca highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT gonzalezfrederic highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT deguibertjeanmanuel highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT fauchermarion highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT sanniniantoine highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation
AT mokartdjamel highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation